BioSpace News Archive

CANTEL MEDICAL CORP. announced that it has completed its previously announced acquisition of Hu-Friedy Mfg.

Alpine Immune Sciences, Inc. announced planned poster presentations at upcoming scientific meetings highlighting new preclinical data on the Company’s lead programs: ALPN-101, a first-in-class dual CD28/ICOS inhibitor for the treatment of autoimmune diseases, and ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancers.

Heron Therapeutics, Inc. announced positive topline results of a multi-center postoperative pain management study in which 51 patients undergoing total knee arthroplasty (TKA) surgery received the investigational agent, HTX-011, together with a scheduled postoperative regimen of generic, oral analgesics (acetaminophen and celecoxib).

Phynd Technologies is pleased to announce that it has become a member of the College of Healthcare Information Management Executives Foundation.

Software integration will help providers augment and extend EHR functionality, driving greater clinician satisfaction

A recent article published in the Aesthetic Surgery Journal, one of the two official publications of The Aesthetic Society, chronicles Breast Implant Illness, and suggests how doctors can help and manage patients describing symptoms.

PanaFarma wins tender to supply social security hospitals with closure system for two years.

Kidney innovation leader bolsters leadership team as it expands nationally

PTC Therapeutics, Inc. announced data demonstrating the ongoing benefit of risdiplam (RG7916) for the treatment of all types of spinal muscular atrophy (SMA) at the 24th International Annual Congress of the World Muscle Society.

DURECT Corporation announced that the U.S. Food and Drug Administration has notified the Company that its Class 2 NDA resubmission for POSIMIR® will be discussed at a meeting of the Anesthetic and Analgesic Drug Products Advisory Committee.